|
|
Quarterly Results |
|
Laurus Labs Ltd | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln | Chairman : M V G Rao | Home : Indian Private | Book Value: 78.057879 | BSE Code : 540222 | Market Cap: 23558.2 | NSE Code : LAURUSLABS | P / E : 105.33 | |
| |
|
|
|
|
|
(Rs in Cr.) |
|
Type | 4Qtr | 3Qtr | 2Qtr | 1Qtr | Net Sales | 1414.52 | 1132.19 | 1158.03 | 1107.65 | Other Income | 24.09 | 10.72 | 5.90 | 6.71 | Total Income | 1438.61 | 1142.91 | 1163.93 | 1114.36 | Total Expenditure | 1143.41 | 961.81 | 977.52 | 979.77 | Operating Profit | 295.20 | 181.10 | 186.41 | 134.59 | Interest | 41.99 | 37.56 | 37.80 | 33.47 | Gross Profit | 253.21 | 143.54 | 148.61 | 101.12 | Depreciation | 88.90 | 86.84 | 85.40 | 83.87 | Tax | 45.94 | 17.27 | 18.30 | 6.43 | Deferred Tax | -2.95 | -3.21 | -1.76 | -2.25 | Reported Profit After Tax | 121.32 | 42.64 | 46.67 | 13.07 |
|
|
|
|
|